IRLA

IRulya Therapeutics Inc.

IRLA | NASDAQ
Chart Builder DCF Calculator
$31.65
-$1.30 (-3.95%)
Nov 2, 2026, 11:42 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Net Income
-83.98M -56.83M -31.39M -51.66M -89.95M -76.85M
Depreciation & Amortization
142K 186K 322K 204K 344K 332K
Stock-Based Compensation
5.11M 4.75M 5.22M 16.62M 29.85M 14.47M
Other Working Capital
13.78M -1.41M 2.27M -3.89M -5.62M 9.75M
Other Non-Cash Items
29.43M 20.48M 5.82M 913K 199K 367K
Deferred Income Tax
-4.96M n/a -248K -284K 878K 635K
Change in Working Capital
12.84M -484K 1.98M -9.83M -4.26M 10.23M
Operating Cash Flow
-41.43M -31.9M -18.29M -44.04M -62.93M -50.82M
Capital Expenditures
-352K -257K -160K -133K -180K -52K
Cash Acquisitions
n/a n/a -2.12M 10.59M -58.95M 52.43M
Purchase of Investments
-34.42M -89.56M -113.78M -75.02M -38.79M -187.14M
Sales Maturities Of Investments
56.98M 109.38M 111.21M 82.49M 97.92M 134.76M
Other Investing Acitivies
1.01M 2.35M -910K 70K 58.95M -52.43M
Investing Cash Flow
23.23M 21.91M -5.76M 18M 58.95M -52.43M
Debt Repayment
n/a n/a -6K -49K n/a -34K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a -5M n/a 148K n/a 1.28M
Financial Cash Flow
17.91M -4.78M 143K 707K 6.81M 118.88M
Net Cash Flow
-403K -14.54M -23.83M -25.15M 2.88M 15.63M
Free Cash Flow
-41.78M -32.16M -18.45M -44.17M -63.11M -50.87M
Adj. Free Cash Flow
-46.88M -36.91M -23.67M -60.79M -92.97M -65.34M
Maintenance CapEx
-142K -186K -160K -133K -180K -52K
Growth CapEx
-210K -71K n/a n/a n/a n/a
Owner Earnings
-41.57M -32.09M -18.45M -44.17M -63.11M -50.87M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.